Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine

Galli, Gloria; Esposito, Gianluca; Dilaghi, Emanuele; Annibale, Bruno; Lahner, Edith; Conti, Laura

doi:10.1016/j.dld.2021.01.007

Cited by 4 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The beginning of COVID-19 vaccination campaigns worldwide has prompted the main medical organizations focused on CD, such as the Society for the Study of Celiac Disease, to comment on the lack of contraindications to the use of available COVID-19 vaccines in CD patients [ 17 ]. Likewise, the authors strongly recommended COVID-19 vaccination in every CD patient, to reduce the morbidity and mortality associated with COVID-19, even if it has not been indicated to have an increased risk of severe outcomes in CD patients [ 9 , 10 , 11 , 12 , 13 , 14 , 30 ]. However, we do not know if CD patients should be encouraged to get vaccinated against COVID-19 with priority because of their chronic autoimmune disorder.…”

Section: Discussionmentioning

confidence: 99%

“…Adherence to a gluten-free diet (GFD) is an effective treatment in most patients. Compared to the general population, those affected by chronic illnesses such as CD may be more apprehensive about COVID-19, although recent data are reassuring [ 9 , 10 , 11 , 12 , 13 , 14 ]. A questionnaire was sent to CD patients, asking whether the COVID-19 pandemic made them feel more vulnerable because of their CD, with 56.6% answering negatively; elderly, women, and patients with other comorbidities were the most apprehensive [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

et al. 2021

View full text Add to dashboard Cite

(1) Background: COVID-19 vaccination campaigns offer the best hope of controlling the pandemic. However, the fast production of COVID-19 vaccines has caused concern among the general public regarding their safety and efficacy. In particular, patients with chronic illnesses, such as celiac disease (CD), may be more fearful. Information on vaccine hesitancy plays a pivotal role in the development of an efficient vaccination campaign. In our study, we aimed to evaluate COVID-19 vaccine hesitancy among Italian CD patients. (2) Methods: an anonymous questionnaire was sent to CD patients followed at our tertiary referral center for CD in Milan, Italy. Patients were defined as willing, hesitant and refusing. We evaluated the reasons for hesitancy/refusal and the possible determinants, calculating crude and adjusted odds ratios [AdjORs] with 95% confidence intervals [CIs]. (3) Results: the questionnaire was sent to 346 patients with a response rate of 29.8%. Twenty-six (25.2%) of the 103 respondents were hesitant, with a total refusal rate of 4.8%. The main reason was fear of adverse events related to vaccination (68.2%). Among hesitant patients, 23% declared that their opinion was influenced by their CD. The determinants positively influencing willingness to be vaccinated against COVID-19 were adherence to a GFD, perception of good knowledge about COVID-19 and its vaccines, and a positive attitude to previous vaccines (AdjOR 12.71, 95% CI 1.82–88.58, AdjOR 6.50, 95% CI 1.44–29.22, AdjOR 0.70, 95% CI 0.11–4.34, respectively). (4) Conclusions: CD patients should be vaccinated against COVID-19 and a specific campaign to address the determinants of hesitancy should be developed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Tampoco se utilizó un cuestionario validado ni se aplicó un muestreo aleatorio. La pandemia por SARS-CoV-2 puedo influenciar en los resultados pues obligó a muchas familias a permanecer más aisladas y se vivieron momentos de tensión y angustia, todo lo cual pudo alterar la calidad de vida de los encuestados e incidir en sus respuestas 25 .…”

Section: Facilidades Y Barrerasunclassified

Facilidades y barreras para la dieta sin gluten de personas con enfermedad celiaca del Paraguay

Delor¹,

Chamorro-Aguilera

2021

Rev Esp Nutr Hum Diet

View full text Add to dashboard Cite

Introducción: el tratamiento de la enfermedad celiaca es la dieta sin gluten, la cual requiere para ser realizada de conocimientos, destrezas y actitudes de los afectados, además de un entorno social propicio. El objetivo fue determinar las circunstancias que facilitan y dificultan la dieta sin gluten en los sujetos con enfermedad celiaca del Paraguay en 2021. Material y métodos: se realizó un estudio exploratorio descriptivo. Se aplicó una encuesta telemática a los adultos, adolescentes y padres de niños con enfermedad celiaca que aceptaban participar voluntariamente. Se midieron variables demográficas, clínicas y 17 aspectos que se presumen son factores facilitadores o barreras para la dieta sin gluten. El estudio fue aprobado por el Comité de Ética de la Universidad Privada del Este, Paraguay. Resultados: se incluyeron 364 encuestas, siendo 85% de adultos. Las circunstancias identificadas como facilitadores fueron los conocimientos propios y los impartidos por el personal de salud sobre la celiaquía, además del poco miedo a la opinión de los demás y los escasos sentimientos de vergüenza por la restricción dietética. En contraste, los factores considerados como barreras fueron el escaso conocimiento de la sociedad sobre las exigencias alimentarias, la poca participación de los encuestados en los grupos de autoayuda y el costo elevado de los alimentos sin gluten. Conclusión: se describen las circunstancias que pueden facilitar y obstaculizar la dieta sin gluten en los portadores de enfermedad celiaca del Paraguay. Se sugieren estudios analíticos para evaluar la influencia exacta de los mismos y aplicar medidas correctivas para disminuir las barreras para la adherencia esta dieta.

show abstract

SARS-CoV-2 induction and COVID-19 manifestations related to autoimmune gastrointestinal diseases

Lerner

Benzvi

2023

Autoimmunity, COVID-19, Post-Covid19 Syndrome and COVID-19 Vaccination

View full text Add to dashboard Cite

Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine

Cited by 4 publications

References 8 publications

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

Facilidades y barreras para la dieta sin gluten de personas con enfermedad celiaca del Paraguay

SARS-CoV-2 induction and COVID-19 manifestations related to autoimmune gastrointestinal diseases

Contact Info

Product

Resources

About